Life Sciences Fund Amsterdam

The Life Sciences Fund Amsterdam is an independent venture capital fund aiming to capitalize on new technological developments in the life sciences sector. It provides investment capital to fund high tech entrepreneurial activity in the Amsterdam Metropolitan Area in general and at the academic medical centres in particular. 

The fund is a specialist fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns. The Fund focuses on seed and early stage companies, but also on pre-seed commercially viable academic projects. To date, the fund’s investments consist of:  AIMM TherapeuticsSigmascreeningRegenesanceACS Biomarker, Caelus Pharmaceuticals and MirNext.
  

Bookmark and Share